Sinopharm Group Co. Ltd. SHTDY

Set alert

Price alert · SHTDY

All alert types
10.31 USD +0.14 +1.38%

At close · Oct 30

10.25 Day range 10.29
9.00 52-week range 14.87
YTD
-16.85%
1 year
-17.45%
Open
10.25
Prev close
10.17
Mkt cap
6.43B
Vol
11.70K
Avg vol
165.68K
EPS
1.62
P/E
6.36
More statistics
Low
10.25
High
10.29

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for SHTDY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

2.14 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A-4 / 5 overall

  • DCF 5
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 1
  • P/E 4
  • P/B 5

Valuation

P/E 7.8×
FY 2016: 16.9×FY 2017: 11.0×FY 2018: 9.0×FY 2019: 7.1×FY 2020: 6.8×FY 2021: 5.5×FY 2022: 6.4×FY 2023: 6.4×FY 2024: 8.8×FY 2025: 7.8×
FY 2016 5y median 6.4× FY 2025
P/S 0.1×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
P/B 0.6×
FY 2016: 2.5×FY 2017: 2.4×FY 2018: 2.0×FY 2019: 1.6×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.8×FY 2024: 0.8×FY 2025: 0.6×
FY 2016 5y median 0.8× FY 2025
P/FCF 4.3×
FY 2016: 10.0×FY 2017: -379×FY 2018: 338×FY 2019: 4.6×FY 2020: 5.4×FY 2021: 6.1×FY 2022: 2.9×FY 2023: 3.9×FY 2024: 6.5×FY 2025: 4.3×
FY 2016 5y median 4.3× FY 2025
EV/EBITDA 4.9×
FY 2016: 7.2×FY 2017: 6.9×FY 2018: 5.9×FY 2019: 4.5×FY 2020: 3.0×FY 2021: 2.7×FY 2022: 2.6×FY 2023: 2.5×FY 2024: 3.7×FY 2025: 4.9×
FY 2016 5y median 2.7× FY 2025
EV/Sales 0.2×
FY 2016: 0.3×FY 2017: 0.3×FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×
FY 2016 5y median 0.1× FY 2025
FCF Yield 23.1%
FY 2016: 10.0%FY 2017: -0.3%FY 2018: 0.3%FY 2019: 21.5%FY 2020: 18.7%FY 2021: 16.5%FY 2022: 34.2%FY 2023: 25.7%FY 2024: 15.5%FY 2025: 23.1%
FY 2016 5y median 23.1% FY 2025

Profitability

Gross Margin 7.2%
FY 2016: 7.9%FY 2017: 8.1%FY 2018: 9.1%FY 2019: 8.8%FY 2020: 8.8%FY 2021: 8.5%FY 2022: 8.6%FY 2023: 8.1%FY 2024: 7.6%FY 2025: 7.2%
FY 2016 5y median 8.1% FY 2025
Operating Margin 2.9%
FY 2016: 4.0%FY 2017: 4.3%FY 2018: 4.5%FY 2019: 3.8%FY 2020: 3.9%FY 2021: 3.8%FY 2022: 3.7%FY 2023: 3.4%FY 2024: 2.8%FY 2025: 2.9%
FY 2016 5y median 3.4% FY 2025
Net Margin 1.2%
FY 2016: 1.8%FY 2017: 2.8%FY 2018: 2.7%FY 2019: 2.5%FY 2020: 1.6%FY 2021: 1.5%FY 2022: 1.5%FY 2023: 1.5%FY 2024: 1.2%FY 2025: 1.2%
FY 2016 5y median 1.5% FY 2025
ROE 8.3%
FY 2016: 14.6%FY 2017: 22.3%FY 2018: 22.0%FY 2019: 22.4%FY 2020: 12.8%FY 2021: 12.5%FY 2022: 12.5%FY 2023: 12.1%FY 2024: 8.9%FY 2025: 8.3%
FY 2016 5y median 12.1% FY 2025
ROIC 5.7%
FY 2016: 9.8%FY 2017: 10.2%FY 2018: 9.4%FY 2019: 9.2%FY 2020: 8.4%FY 2021: 8.8%FY 2022: 8.6%FY 2023: 7.8%FY 2024: 5.8%FY 2025: 5.7%
FY 2016 5y median 7.8% FY 2025
ROA 1.8%
FY 2016: 2.9%FY 2017: 4.6%FY 2018: 4.0%FY 2019: 3.9%FY 2020: 2.3%FY 2021: 2.3%FY 2022: 2.3%FY 2023: 2.4%FY 2024: 1.8%FY 2025: 1.8%
FY 2016 5y median 2.3% FY 2025

Growth (YoY)

Revenue -4.3%
FY 2016: 12.9%FY 2017: 7.3%FY 2018: 24.4%FY 2019: 23.4%FY 2020: 7.3%FY 2021: 14.2%FY 2022: 6.0%FY 2023: 8.0%FY 2024: -2.0%FY 2025: -4.3%
FY 2016 FY 2025
Operating Income 0.1%
FY 2016: 10.9%FY 2017: 16.6%FY 2018: 29.3%FY 2019: 4.8%FY 2020: 10.1%FY 2021: 11.0%FY 2022: 4.5%FY 2023: -1.9%FY 2024: -19.9%FY 2025: 0.1%
FY 2016 FY 2025
EPS (diluted) -1.8%
FY 2016: 23.5%FY 2017: 57.7%FY 2018: 19.2%FY 2019: 13.0%FY 2020: -35.3%FY 2021: 7.8%FY 2022: 9.6%FY 2023: 6.2%FY 2024: -22.1%FY 2025: -1.8%
FY 2016 FY 2025
Free Cash Flow 30.7%
FY 2016: -36.3%FY 2017: -102.9%FY 2018: 209.8%FY 2019: 6401.2%FY 2020: -44.1%FY 2021: -22.2%FY 2022: 163.0%FY 2023: -20.0%FY 2024: -35.4%FY 2025: 30.7%
FY 2016 FY 2025

Financial Health

Current Ratio 1.4×
FY 2016: 1.3×FY 2017: 1.3×FY 2018: 1.3×FY 2019: 1.3×FY 2020: 1.3×FY 2021: 1.3×FY 2022: 1.4×FY 2023: 1.4×FY 2024: 1.4×FY 2025: 1.4×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 1.1×
FY 2016: 1.1×FY 2017: 1.1×FY 2018: 1.1×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 1.1×FY 2022: 1.1×FY 2023: 1.1×FY 2024: 1.1×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 1.3×
FY 2016: 1.1×FY 2017: 1.0×FY 2018: 1.3×FY 2019: 1.2×FY 2020: 1.2×FY 2021: 1.1×FY 2022: 1.0×FY 2023: 1.0×FY 2024: 1.0×FY 2025: 1.3×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 2.3×
FY 2016: 0.7×FY 2017: 0.5×FY 2018: 0.9×FY 2019: 0.8×FY 2020: 0.8×FY 2021: 1.0×FY 2022: 0.5×FY 2023: 0.4×FY 2024: 1.0×FY 2025: 2.3×
FY 2016 5y median 1.0× FY 2025
Interest Coverage 6.7×
FY 2016: 5.0×FY 2017: 4.6×FY 2018: 3.7×FY 2019: 4.7×FY 2020: 5.2×FY 2021: 5.2×FY 2022: 5.9×FY 2023: 6.8×FY 2024: 5.9×FY 2025: 6.7×
FY 2016 5y median 5.9× FY 2025

Dividends

Dividend Yield 3.9%
FY 2016: 1.4%FY 2017: 1.6%FY 2018: 1.9%FY 2019: 2.3%FY 2020: 3.8%FY 2021: 5.0%FY 2022: 4.3%FY 2023: 4.4%FY 2024: 4.4%FY 2025: 3.9%
FY 2016 5y median 4.4% FY 2025
Payout Ratio 30.5%
FY 2016: 24.4%FY 2017: 17.6%FY 2018: 16.8%FY 2019: 16.5%FY 2020: 26.0%FY 2021: 27.8%FY 2022: 27.5%FY 2023: 28.3%FY 2024: 38.5%FY 2025: 30.5%
FY 2016 5y median 28.3% FY 2025

Annual · latest fiscal year ends 2025-12-31